Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6389 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
81-11 Xigduo XR AstraZeneca AB Original drug approved in China Original drug imported to China The 81st Batch of Reference Listed Drugs
81-12 Xigduo XR AstraZeneca AB Original drug approved in China Original drug imported to China The 81st Batch of Reference Listed Drugs
81-13 Xigduo XR AstraZeneca AB Original drug approved in China Original drug imported to China The 81st Batch of Reference Listed Drugs
81-14 NOXAFIL SCHERING CORP/Merck Sharp &Dohme Corp. Original drug not imported to China US Orange Book The 81st Batch of Reference Listed Drugs
81-15 KORSUVA CARA THERAPEUTICS INC Original drug not imported to China US Orange Book The 81st Batch of Reference Listed Drugs
81-16 EVOMELA ACROTECH BIOPHARMA INC Original drug not imported to China US Orange Book The 81st Batch of Reference Listed Drugs
81-17 Tabrecta Novartis Pharmaceuticals Corporation Original drug not imported to China US Orange Book The 81st Batch of Reference Listed Drugs
81-18 Tabrecta Novartis Pharmaceuticals Corporation Original drug not imported to China US Orange Book The 81st Batch of Reference Listed Drugs
81-19 Sporanox Janssen Pharmaceuticals, Inc Original drug not imported to China US Orange Book The 81st Batch of Reference Listed Drugs
81-20 Millipred WATSON LABORATORIES INC Internationally recognized to be equivalent to the original drug US Orange Book The 81st Batch of Reference Listed Drugs